Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their lives. Our noble purpose guides our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and pioneering medical dermatology products to bring our innovative solutions to patients in need.

The company, founded in 1943 and based in Barcelona, ??is listed on the Spanish Stock Exchange and is a member of the IBEX 35 (ticker: ALM). Throughout its 77-year history, Almirall has maintained a strong commitment to the needs of patients. Currently, Almirall has a direct presence in 21 countries and strategic agreements in more than 70, through 13 subsidiaries, with approximately 1,800 employees. Total revenue in 2020 was 814.5 million euros.